Bill Gates Malaria Vaccine Flops In African Trials

Bill Gates Malaria Vaccine Flops In African Trials







Brandon Turbeville


Activist Post



In what may prove to be a minor public relations setback for vaccine
pushers like Bill Gates and GlaxoSmithKline, the much touted Mosquirix
malaria vaccine recently rolled out in Africa has been officially
demonstrated to be only 30% effective in babies.

Results from the final-stage trial administered by GSK appeared to
demonstrate that the vaccine only provided “modest protection” for
babies aged six to 12 weeks, with a reduction in the contraction of the
disease by only 30%, a much lower number than what had been touted by
those promoting the jab in the industry and the corporate media.

Reuters also reports
that for children after the age of six months, a 65% rate was
established. For children of five to 17 months old, the researchers
claim a protection of around 50%.


In response to what Reuters has dubbed a “surprisingly poor result” for
the vaccine, Bill Gates stated, “The efficacy came back lower than we
had hoped, but developing a vaccine against a parasite is a very hard
thing to do.”

Indeed, Gates is correct in suggesting the difficulty
for creating a vaccine for a Protozoan, the type of parasite which
causes malaria, This is because vaccines are supposedly designed to
protect against viruses. Thus, the Mosquirix vaccine enters into the
growing science of DNA vaccines – a research field which is expanding
but also one in which the science is still very much out in regards to
effectiveness, safety, and even possibility.

Nevertheless, GSK has announced that it will not be giving up in the
attempt to develop Mosquirix into a more “effective” vaccine, and will
be working with governments and international groups in order to fund
the operation. GSK claims it does not plan to make a profit from
Mosquirix, although it admits that it will be charging a 5% profit
margin on the product. The funding for the development and rollout, of
course, will be coming from the governments and international groups
mentioned above, meaning it is the cash-strapped taxpayer who must
shovel out the cash for yet another eugenics program aimed at poor
Africans.

Interestingly enough, it was Bill Gates himself who once stated,
“The world today has 6.8 billion people... that's headed up to about 9
billion. Now if we do a really great job on new vaccines, health care,
reproductive health services, we could lower that by perhaps 10 or 15
percent.”

Of course, it bears noting, especially in this context, that the results
of the GSK study show only a 30% efficacy rate yet the companies,
governments, and international “groups” behind the push are continuing
to move forward with plans for yet more vaccination programs whose
harmful effects have not been properly studied.

Yet,
even the 30% itself is highly suspect considering the fact that there
has never been a study proving that vaccines are either safe or effective that itself was not connected to a vaccine maker or pharmaceutical company.[1]

The fact that the ineffectiveness of the malaria vaccine is being
announced openly by the corporation that created it as well as one of
the most notorious vaccine pushers in the world is striking. With this
in mind, one could be led to suppose that the real percentage of
efficacy might be even lower if non-politicized science were applied to
it.

In the end, the real goal of such vaccine programs as those currently being funded in Africa is a eugenics-based, population reduction philosophy that permeates governments, corporations, NGO’s, and academia.
Unfortunately, it is for this reason that open the open failure of the
malaria vaccine will do little to deter the expense of more money, more
time, and more propaganda being spent toward the goal of vaccinating and
reducing the vast majority of the population of Africa.

Source:-
http://www.activistpost.com/2012/11/bill-gates-malaria-vaccine-flops-in.html